TKNO logo

ALPHA TEKNOVA INC

TKNONASDAQ
πŸ† #2980 by market capEarnings Nov 4US Equity
$7.53β–² $0.14 (+1.83%)
Live
1hβ–² 0.1%
24hβ–² 1.8%
7dβ–² 15.2%
14dβ–² 46.5%
30dβ–² 40.8%
1yβ–² 54.2%
🏦Market Cap
$403M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+7.3%
Slowing
πŸ“ŠGross Margin
33.9%
Moderate
πŸ’΅FCF Margin
-16.4%
Thin
βš–οΈP/S Ratio
9.2x
Elevated
Otter Score
57
Weak

Trading Snapshot

Day Range
$7.45 – $7.56
52-Week Range
$1.91 – $7.75
Volume
$5.12B
Avg Volume
$3.63B
Shares Outstanding
53.6M
Next Earnings
Sep 27, 2026

Fundamentals Snapshot

Annual Revenue
$41M
Last Q Revenue
$12M
P/E Ratio
-23.9
P/S Ratio
9.2x
EPS (TTM)
$-0.31
Dividend Yield
0.00%

Why Investors Own TKNO

  • βœ“High-growth profile β€” revenue up +3.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 68% gross margin and 14% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue
$41Mβ–² +7.4% YoY
Gross Margin
33.2%β–² +73.2% YoY
Operating Income
βˆ’$17Mβ–Ό βˆ’35.1% YoY
Free Cash Flow
βˆ’$10Mβ–Ό βˆ’27.5% YoY

About ALPHA TEKNOVA INC

Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
57/100

Analyst Ratings

β“˜
Consensus
Buy
12 analysts
Strong Buy4
Buy5
Hold3
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates